# Rylaze

NDC: 68727-900
Generic name: asparaginase erwinia chrysanthemi (recombinant)-rywn
Labeler / Manufacturer: Jazz Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20210630

FDA application: BLA761179

## Active ingredients

- ASPARAGINASE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68727-900"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68727-900
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=857e53aa-1098-4dad-b654-0276cdd43e03